Leading nanoscientists representing the key disciplines in chemistry, physics, biology, materials science, engineering, medicine, and carbon nanotubes, and including National Academy of Sciences members, and a Feynman Nanotechnology Prize winner, provide the company with a formidable Scientific Advisory Board (SAB).  The firm’s Corporate Development Team leverages expertise in high-tech valuation, nanotech-specific accountancy, intellectual property (IP) and securities proficiency, human capital search capability, as well as financial PR and investor relations (IR) know-how for the benefit of its clients.